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Background: Oral therapies and chemodenervation procedures are often unrewarding in
the treatment of focal, task-specific hand disorders such as writer’s cramp or primary writ-
ing tremor (PWT).
Methods: A portable writing orthotic device (WOD) was evaluated on 15 consecutively
recruited writer’s cramp and PWT subjects. We measured overall impairment at baseline
and after 2 weeks of at-home use with theWriter’s Cramp Rating Scale (range=0–8, higher
is worse) and writing quality and comfort with a visual analog scale (range=0–10).
Results: Compared to regular pen, the WOD improved the Writer’s Cramp Rating Scale
scores at first-test (p=0.001) and re-test (p=0.005) as well as writing quality and device
comfort in writer’s cramp subjects. Benefits were sustained at 2 weeks. PWT subjects
demonstrated no improvements.
Conclusion:WODs exploiting a muscle-substitution strategy may yield immediate benefits
in patients with writer’s cramp.
Keywords: orthotic devices, medical devices, writer’s cramp, primary writing tremor, task-specific hand dystonia,
writer’s cramp rating scale
INTRODUCTION
Focal task-specific hand dystonia (writer’s cramp, WC) results
from involuntary activation of antagonistic pairs of muscles of
the hand, wrist, and elbow during the fine finger movements of
handwriting (Ceballos-Baumann et al., 1997). WC may be gen-
erated from abnormalities in the motor circuitry within the basal
ganglia and interconnected motor areas with resulting degradation
of the cortical representation of the motor task and loss of nor-
mal surround inhibition for specific motor programs at the cortex
(Ranawaya and Lang, 1991; Ridding, 1995; Lerner et al., 2004).
Other suggested causes of WC are impaired sensorimotor inte-
gration (Serrien et al., 2000) and abnormal brainstem inhibitory
mechanisms (Cohen, 1989; Chen et al., 1997). Studies have shown
that WC patients may have abnormal homuncular organization
of tactile sensory perception (Bara-Jimenez et al., 1998). Abnor-
mal sensory tactile perception may elicit hyperactivation of motor
areas involved in finger movement.
Writer’s cramp is challenging to treat. Anticholinergic agents
(Lang, 1982), botulinum toxin (BTX) injections, and deep brain
stimulation (DBS) have been used as treatment modalities for
WC. Frequent problems with tolerability restrict the efficacy of
anticholinergic drugs. Though studies have confirmed the clinical
efficacy of BTX, its use is limited because of high cost and common
adverse side effects, particularly excessive weakness limiting gross
and fine-motor hand functions other than handwriting (Poung-
varin, 1991; Wissel et al., 1996). The use of DBS is rarely advocated
for WC as the potential risks may outweigh its restricted disability
(Collins et al., 2010).
Prior evidence suggests that the application of muscle-
substitution strategies may be beneficial in WC patients (Espay
et al., 2005; Zeuner, 2005). Modifying the standard handwrit-
ing posture changes the handwriting technique, replacing the
abnormal motor program with a normal behavior that “re-tunes”
the sensorimotor circuitry. This behavior-modification strategy,
also called sensory-motor retuning (SMR), has been shown to
be effective in treating musician’s cramp [which shares similar
pathophysiologic features with WC (Candia et al., 2005)]. Studies
conducted with WC patients showed improvement after handwrit-
ing modification techniques (Ranawaya, 1991; Schenk et al., 2004).
We conducted a pilot study to measure dystonic posture, writing
quality, and user comfort with the use of a writing orthotic device
(WOD), built with direct patient feedback over several iterations,
that modifies handwriting posture in consecutively recruited sub-
jects with WC and with another task-specific disorder, primary
writing tremor (PWT). A WOD was offered to these subjects
as a non-invasive, cheap to manufacture, and simple alternative
intervention to chemodenervation and oral therapies.
MATERIALS AND METHODS
SUBJECTS
We recruited consecutively referred adult subjects with WC and
PWT from the University of Cincinnati Gardner Family Cen-
ter for Movement Disorders for this exploratory study. Sub-
jects received no BTX injections or other medical interven-
tions within 3 months prior to study enrollment. Subjects with
non task-specific dystonia or tremor or who had undergone
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functional neurosurgical interventions, segmental, or generalized
dystonia were excluded. All subjects provided Institutional Review
Board-approved informed consent prior to their participation.
DATA ACQUISITION
Subjects were examined at baseline with a regular ballpoint pen
(baseline test) followed immediately thereafter with the WOD
(first-test); and reexamined 2 weeks after daily at-home use of
the WOD (re-test). At each of these assessments, subjects com-
pleted standardized handwriting tasks and spiral drawing. The
WOD forces a modified handwriting technique, whereby the pen
is placed between the thumb and index finger using a see-through
palm-sized holder (Figure 1). The standardized tasks required
subjects to (1) write the word “Sunshine” six times, (2) write
the sentence “Today is a sunny day” three times, and (3) to draw
an Archimedes spiral. The first two tasks were designed to assess
dystonic posture and the last task was used for quantification of
tremor.
MEASUREMENTS
The tasks were rated using the Writer’s Cramp Rating Scale
(WCRS; Wissel et al., 1996; Kruisdijk, 2006; Zeuner, 2007, 2008).
The WCRS rates dystonic posturing of the elbow,wrist, and fingers;
latency of dystonia and tremor; and writing speed (range= 0–30,
higher is worse). Subjects also assessed the magnitude of change
in writing quality and user comfort through a visual analog scale
(VAS, range= 1–10; 5= no change, ≥6=WOD was beneficial;
≤4=WOD was detrimental) compared to the regular pen. The
subjects were asked to practice at home with the WOD to enhance
comfort and ease of use prior to a reassessment (re-test) visit
2 weeks later. Subjects were also encouraged to use the WOD
instead of a regular pen during this period of 2 weeks. At the re-test
visit, subjects were asked to repeat the three WCRS-required tasks
and estimate their VAS-based changes in writing quality and user
comfort from baseline.
THE WRITING ORTHOTIC DEVICE
The WOD (Figure 1A) was created from 3/4′′ acrylic sheets that
were laser cut by a BEAM Dynamics Laser Cutter at the University
of Cincinnati College of Design Art, Architecture, and Planning. It
is approximately 3′′ long and 3′′ wide. There are three pre-drilled,
3/4′′ diameter, pen-holes for placement of a pen of choice. The
WOD was created after several iterations using patient feedback
for ergonomics and portability using Solidworks™CAD software.
It was designed to mold to the hand between the thumb and index
finger. Because of its design, it can work in either hand by turn-
ing it upside down (Figure 1B). We printed three different sizes
to tailor it to a range of hand sizes. After extensive user feed-
back and about a dozen iterations, we chose acrylic because of its
high tensile integrity and transparency, to ensure strong grip and
adequate visibility of the tip of the pen and of the text being writ-
ten (Figure 1C). Furthermore, the WOD fits the entire palm for
increased stability and ergonomic support. When subjects write,
the wrist is fixed while most of the writing movements take place
proximally, at the elbow and shoulder. This forced change in the
motor program was meant to provide the muscle-substitution
FIGURE 1 | (A) WOD design in transparent material to allow writing visibility.
(B) Posture of the hands during handwriting with the WOD. The pen is
removable and exchangeable at any of several holes (arrows) to optimize
individual handwriting techniques. (C) The WOD shown with a pen through
one of the holes. (D) “Sunshine” writing task before (left) and with the use of
the WOD (right) in one of the participating subjects.
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strategy hypothesized to decrease or eliminate dystonic activity
during handwriting.
DATA ANALYSIS
The mean, median, standard deviation, interquartile range (IQR),
and range were used to describe quantitative variables. Frequency
and proportions were used for categorical variables. The repeated
scores (baseline test, first-test, and re-test) for WCRS and tremor
were compared using Friedman test followed by Wilcoxon signed
rank test in post hoc comparisons after adjusting level of signifi-
cance. Comfort and writing quality scores between first-test and
re-test were compared using Wilcoxon signed rank test. The sta-
tistical analyses were carried out using IBM ®SPSS®Statistics Base
Grad Pack 19.
RESULTS
Fifteen subjects [9 males; 14 Caucasian; mean age,53.7± 12.6 years
(range, 36–76); mean age at disease onset, 33.6± 11.6 years (range,
15–48)] participated in the study. Two patients failed to complete
study because of lack of adaptability to the WOD and two patients
were lost to follow-up. Eleven subjects (64.7%) were diagnosed
with WC and four (23.5%) with PWT.
There was significant improvement in WCRS scores at first-
test (p= 0.001) and re-test (p= 0.005) from baseline test in WC
subjects (Table 1). The magnitude of improvement was sustained,
as demonstrated by similar scores between first-test and re-test at
2 weeks. Although tremor scores were reduced, the difference was
not significant in PWT subjects (p= 0.057).
Writing comfort and quality scores improved with the WOD
compared with the regular pen at first-test (mean, 6.2± 2.2
vs. 7.7± 1.6, respectively). These variables did not significantly
change at re-test (p= 0.59 vs. 0.77, respectively). A dramatic
improvement in writing quality could be observed in selected
subjects (Figure 1D).
DISCUSSION
Our pilot data suggest that the use of an orthotic handwrit-
ing device can improve handwriting in patients with WC. The
benefit of WODs on WC may result from the application of a
muscle-substitution strategy, by altering the hand and finger pos-
ture during handwriting, independently or through an open-loop
sensory feedback mechanism. The improvement of handwriting
in WC but not in PWT patients by altering the aberrant motor pro-
gram further emphasizes that PWT is not a form of focal dystonia,
adding to the growing body of evidence supporting the concept
that PWT and WC are distinct task-specific disorders, with differ-
ent pathophysiology and response to treatment (Espay and Chen,
2011).
Several studies have suggested that altering hand posture mod-
ify the sensorimotor circuits and prevent excessive activation of
antagonistic muscle groups involved in WC (Zeuner, 2005; Espay
and Chen, 2011). WODs that alter handwriting posture and tech-
nique have therapeutic potential in treating focal, task-specific dys-
tonias and can be cheap and safe alternatives to chemodenervation
and oral anticholinergic drugs. Abnormal patterns of supplemen-
tary motor area and primary sensorimotor cortex activation in
Table 1 | Comparisons of WCRS and tremor scores.
Variables Baseline
(IQR)
First-test
median (IQR)
Re-test
median (IQR)
p-Value
WCRS (n=11) 7 (6, 8) 3 (1, 4.3) 2 (2, 5) <0.001
Tremor (n=4) 3 (1.5, 5.5) 1 (0, 3.5) 2 (0, 3) 0.057
IQR, interquartile range.
WC have been identified using fMRI (Oga et al., 2002), which may
help in future correlative studies.
To quantify the severity of symptoms, we relied on the WCRS,
previously used in various WC studies (Kruisdijk, 2006; Zeuner,
2007, 2008). We found that the effects of the WOD were imme-
diately apparent at the baseline visit. Furthermore, the magnitude
of benefits was sustained at the 2 week reevaluation, without addi-
tional gains made beyond those observed at the outset. The quality
and comfort scores were adequate at the initial visit with no addi-
tional improvements documented at the reevaluation, suggesting
that training may not be necessary for accrual of benefits, although
further improvements may be possible with a longer training
period.
The WOD to alter handwriting posture was created in-house
and fine-tuned over several cycles with patient-generated feed-
back. Additional feedback was collected from physicians, physical
therapists, and biomedical engineers. One prior study assessing
the effect of an orthotic device for WC was deemed “too bulky”
(Ranawaya, 1991). For this reason, the WOD was designed to easily
fit into anyone’s pocket for mobility. Nevertheless, exit feedbacks
provided by our subjects suggested that the WOD was, at times,
still awkward to use in public and this may limit its widespread
use. Given more time and practice, subjects may feel less awk-
ward. Furthermore, some subjects suggested that the device was
too rigid and, at times, it was hard to see what was being writ-
ten. This may explain the lower than expected writing quality
and comfort scores. An improved design that makes the device
more flexible and customizable with a variety of pens may improve
scores. There were several limitations to this study. Because it was
an exploratory study, sample population was small and the data
was analyzed unblinded. Although the study design limits positive
conclusions until verified with a larger sample size, it demonstrates
that use of WODs may benefit patients with WC. Although logis-
tically complicated, only double-blind randomized trials on larger
samples of WC patients can ascertain the true efficacy of this and
other non-invasive techniques to treat WC. Another perceived lim-
itation with regards to this study is that the time for follow-up was
of only 2 weeks. Longer training and follow-up might have further
improved quality and speed of writing experienced by the sub-
jects and provided a more accurate estimate of intolerability to
the WOD.
In sum, the WOD is a cost-effective, simple, and non-invasive
treatment alternative to chemodenervation and DBS for the
management of the restricted disability of WC. Larger sam-
ple sizes will be necessary to confirm these preliminary find-
ings and determine the “dose” of WOD required for optimal
benefits.
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